2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$12.99+$0.15 (+1.17%)
Price as of Oct 02, 2026 4:15 PM EDT- $374.0MMarket Cap
- 24.30%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$12.99+$0.15 (+1.17%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.84 | ||
Change | -$0.34 (-2.58%) | ||
Open | $13.08 | ||
High | $13.45 | ||
Low | $12.83 | ||
Previous Close | $13.18 | ||
Volume | 331,488 | ||
30-Day Average Volume | 267,026 | ||
1-Week Change | 7.00% | ||
1-Month Change | -4.96% | ||
1-Year Change | 24.30% | ||
3-Year Change | 14.95% | ||
5-Year Change | -78.94% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $296.9M | ||
Market Cap | $374.0M | ||
Enterprise Value | $340.6M | ||
Period: QTR TTM FY | |||
Revenue | $14.4M | ||
Net Income | -$19.5M | ||
Free Cash Flow | -$10.0M | ||
EBIT | -$15.3M | ||
EBITDA | -$14.2M | ||
Net Working Capital | $149.5M | ||
EPS | -$0.67 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 4 | ||
P/E | -19 | ||
PEG | 0 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||